Placental Malaria is associated with reduced early life weight development of affected children independent of low birth weight

listen audio

Study Justification:
This study aimed to investigate the impact of Plasmodium falciparum infection during pregnancy on the long-term growth and development of infants. While it is known that placental malaria can lead to low birth weight and increased infant morbidity and mortality, the specific effects on growth development independent of low birth weight are not well understood. This study aimed to fill this knowledge gap and provide a better understanding of the long-term effects of placental malaria.
Highlights:
– The study found that infants exposed to placental malaria during pregnancy had significantly lower weight-for-age, weight-for-length, and BMI-for-age z-scores compared to infants born to mothers without placental malaria, even after adjusting for low birth weight.
– The data also showed a decline in placental malaria prevalence over time in the study population.
– These findings suggest that the negative impact of placental malaria on infant growth development has been underestimated, even in areas where malaria transmission is declining.
Recommendations:
Based on the study findings, the following recommendations can be made:
1. Improve prevention and treatment of placental malaria during pregnancy to reduce the negative impact on infant growth and development.
2. Increase awareness among healthcare providers and pregnant women about the potential long-term effects of placental malaria on infant health.
3. Conduct further research to better understand the mechanisms through which placental malaria affects infant growth and development, and to identify potential interventions to mitigate these effects.
Key Role Players:
To address the recommendations, the following key role players are needed:
1. Healthcare providers: They play a crucial role in preventing and treating placental malaria during pregnancy. They need to be trained on the latest guidelines and best practices for managing placental malaria.
2. Pregnant women: They should be educated about the risks of placental malaria and the importance of seeking early diagnosis and treatment.
3. Researchers: Further research is needed to better understand the long-term effects of placental malaria and to develop effective interventions.
4. Policy makers: They need to prioritize the prevention and treatment of placental malaria and allocate resources accordingly.
Cost Items:
While the actual cost of implementing the recommendations will vary depending on the context, some key cost items to consider in planning the recommendations include:
1. Training and capacity building for healthcare providers: This includes the cost of organizing training workshops, developing educational materials, and providing ongoing support and supervision.
2. Diagnostic and treatment tools: This includes the cost of procuring and distributing diagnostic tests and antimalarial drugs for the prevention and treatment of placental malaria.
3. Research funding: Further research to understand the mechanisms and develop interventions will require funding for study design, data collection, analysis, and dissemination.
4. Awareness campaigns: The cost of developing and implementing awareness campaigns targeting pregnant women and the general public to increase knowledge about placental malaria and its long-term effects.

The strength of evidence for this abstract is 8 out of 10.
The evidence in the abstract is strong, but there are some areas for improvement. The study design is well-described, and the sample size is adequate. The results show a significant association between placental malaria and reduced weight development in infants, independent of low birth weight. However, there are a few suggestions to improve the evidence: 1) Include information on the statistical methods used to analyze the data, such as the specific generalized estimating equations models. 2) Provide more details on the demographic and socio-economic characteristics of the study population, as these factors may confound the association between placental malaria and weight development. 3) Clarify how the placental histology was performed and how the cases were classified. 4) Consider conducting a follow-up study to assess the long-term effects of placental malaria on growth and development beyond the first year of life.

Background: Infection with Plasmodium falciparum during pregnancy contributes substantially to the disease burden in both mothers and offspring. Placental malaria may lead to intrauterine growth restriction or preterm delivery resulting in low birth weight (LBW), which, in general, is associated with increased infant morbidity and mortality. However, little is known about the possible direct impact of the specific disease processes occurring in PM on longer term outcomes such as subsequent retarded growth development independent of LBW. Methods. In an existing West-African cohort, 783 healthy infants with a birth weight of at least 2,000 g were followed up during their first year of life. The aim of the study was to investigate if Plasmodium falciparum infection of the placenta, assessed by placental histology, has an impact on several anthropometric parameters, measured at birth and after three, six and 12 months using generalized estimating equations models adjusting for moderate low birth weight. Results. Independent of LBW, first to third born infants who were exposed to either past, chronic or acute placental malaria during pregnancy had significantly lower weight-for-age (-0.43, 95% CI: -0.80;-0.07), weight-for-length (-0.47, 95% CI: -0.84; -0.10) and BMI-for-age z-scores (-0.57, 95% CI: -0.84; -0.10) compared to infants born to mothers who were not diagnosed with placental malaria (p = 0.019, 0.013, and 0.012, respectively). Interestingly, the longitudinal data on histology-based diagnosis of PM also document a sharp decline of PM prevalence in the Sukuta cohort from 16.5% in 2002 to 5.4% in 2004. Conclusions. It was demonstrated that PM has a negative impact on the infant’s subsequent weight development that is independent of LBW, suggesting that the longer term effects of PM have been underestimated, even in areas where malaria transmission is declining. © 2010 Walther et al; licensee BioMed Central Ltd.

Data were collected from children born between January 2002 and July 2005 as part of an ongoing open cohort study at the maternity ward of the Health Centre in Sukuta, a semi-urban Gambian village 30 km south of the capital Banjul, where malaria transmission varies considerably between season, with highest incidence during the wet season and immediately afterwards (‘malaria season’: August – December). The main study, as well as the analysis strategy of the data presented here, was approved by the Joint Gambian Government/MRC Ethics Committee. The newborns delivered at the maternity ward were enrolled after informed consent of the mother was obtained. The purpose of the main cohort was to study immune responses of infants to vaccines and infections. Since overt morbidity, as well as risk factors associated with LBW, are known to increase susceptibility to infectious diseases and thus bias any immunological responses [32-35] only healthy singleton children were eligible for recruitment into the cohort. Newborns below a birth weight of 2,000 g were excluded from the study. A survey among Gambian pregnant women in 2000-01 [36] estimated the prevalence of HIV to be 1.0% (CI: 0.9-2.4%) in Serekunda, an urban settlement approximately 10 km from Sukuta. Based on this estimate, HIV+ cases are unlikely to have significantly impacted on the results of this study, and following ethical guidance HIV testing was not performed. Demographic, anthropometric and clinical data from 783 mother/child pairs were used to investigate the association of maternal PM and height and weight in the first year of life of the offspring. Basic demographic and socio-economic data, such as, ethnicity, age, and parity of the mother, education of the parents and, as a measure for overcrowding, number of persons sleeping in one bedroom, as well as information on malaria treatment and bednet use were collected in face-to-face interviews by trained fieldworkers using questionnaires shortly after birth. Infants were followed up monthly over a 12-month period for morbidity and anthropometric measurements. At each follow up visit trained nurses recorded the number of illness episodes during the previous month reported by the mother or guardian of the child and administered vaccines according to the recommended Gambian Expanded Programme of Immunization schedule. Maternal height and weight were recorded six months after delivery. PM status was defined by placental histology. After birth a placental biopsy was taken and embedded in paraffin and stained for histological analysis of PM status [29]. Cases were classified according to Ismail [37] as active infection (presence of infected red blood cells in the intervillous space of the placenta) and past infection (no parasites, but haemozoin deposition in macrophages). Active infection was further subdivided into acute infections (only parasites and minimal haemozoin deposition) and chronic infections (parasites and significant haemozoin deposition). Childrens’ weight and length measurements at three, six and 12 months of age (+/- 15 days) were used to calculate four age/gender-standardized indicators: ‘weight-for-age’ (wfa), ‘length-for-age’ (lfa), ‘weight-for-length’ (wfl) and ‘body-mass-index-for-age’ (BMIfa) based on the WHO “Child Growth Standards, 2006” using the Stata macro ‘igrowup.ado'[38]. All data were double entered into an Access database (Microsoft), validated and checked for range and consistency. Prior to investigating if PM is associated with infant’s size and nutritional status, univariable analyses were used to assess whether known PM risk factors (young maternal age, low parity, low socio-economic status, no bednet use, and seasonality of malaria transmission) [6] were present in this study population. A logistic regression model was fitted including all risk factors with p-values less than 0.2 in univariable analysis, which were kept in the model at a significance level p ≤ 0.05. The final model including parity, PM season and year, and duration of schooling of the mother was used to calculate adjusted ORs and corresponding p-values of being PM+ comparing the individual exposure groups to a specified baseline group. The hypothesis that exposure to PM would be associated with lower values for anthropometric indicators was tested at each of the three time points three, six and 12 months using univariable analyses first. Additional mother and child characteristics such as maternal age, height, BMI, parity, duration of schooling, living in crowded housing conditions as well as gender of the child, moderate low birth weight of 2,000 g – 2,499 g, current age of the child, month and year of birth, and whether the child was born in the ‘hungry’ season (during the months with intensive rain fall from July to October) [39,40] were investigated as risk factors for reduced indicators. Univariable analyses were conducted to examine the association of each factor with the four anthropometric indicators described above at three, six and 12 months of age. Cross-sectional times series models using generalized estimating equations (GEE) to fit the parameters of the models with exchangeable correlation structure were then constructed for each anthropometric indicator. The final models account for multiple weight and length measurements at three, six and 12 months of age and confounding factors such as sex, moderate low birth weight of 2,000 g – 2.499 g, infant’s age, birth month and year, parity and education (duration of schooling) of the mother. An interaction term was included for PM exposure status of the child and parity to investigate if the association of PM and size of the infant varied between parity groups. Since the association of PM and the growth indicators wfa, wfl and BMIfa was not significantly different for two or three pregnancies, but for more than four pregnancies compared to the first pregnancy, data was split into two groups according to 1-3 and 4 and more pregnancies. Maternal age and living in crowded housing conditions lacked a significant association with z-scores and was therefore not included in the final models. Mother’s height and BMI were not considered, since 61% of the data were missing. No difference was seen for anthropometric measurements taken during or after the ‘hungry’ season; thus “hungry season” was not included in the models. The resulting models were used to assess the effect of PM exposure on each anthropometric indicator independent of birth weight. Whether maternal exposure to PM was associated with being underweight, wasted or stunted (wfa, wfl or lfa z-scores<-2, respectively) was investigated using logistic regression. Odds ratios for the group of wasted or underweight infants and a second group of stunted infants were calculated choosing all the remaining well-nourished infants as the baseline group.

Based on the information provided, here are some potential innovations that could improve access to maternal health:

1. Telemedicine: Implementing telemedicine services can provide remote access to healthcare professionals, allowing pregnant women in remote or underserved areas to receive prenatal care and consultations without having to travel long distances.

2. Mobile health (mHealth) applications: Developing mobile applications that provide educational resources, appointment reminders, and personalized health information can empower pregnant women to take control of their own health and access important maternal health services.

3. Community health workers: Training and deploying community health workers who can provide basic prenatal care, education, and support to pregnant women in their communities can help improve access to maternal health services, especially in areas with limited healthcare infrastructure.

4. Transportation solutions: Developing transportation solutions, such as mobile clinics or transportation vouchers, can help overcome geographical barriers and ensure that pregnant women can easily access healthcare facilities for prenatal care and delivery.

5. Maternal health clinics: Establishing dedicated maternal health clinics in underserved areas can provide comprehensive prenatal care, delivery services, and postnatal care in one location, making it easier for pregnant women to access the care they need.

6. Health education programs: Implementing targeted health education programs that focus on maternal health and pregnancy-related issues can help raise awareness and empower pregnant women to seek timely and appropriate care.

7. Financial incentives: Providing financial incentives, such as cash transfers or subsidies, to pregnant women who attend prenatal care visits and deliver at healthcare facilities can help overcome financial barriers and encourage women to seek appropriate maternal health services.

8. Public-private partnerships: Collaborating with private sector organizations, such as pharmaceutical companies or technology companies, can help leverage their resources and expertise to develop innovative solutions for improving access to maternal health.

It is important to note that these recommendations are general and may need to be tailored to the specific context and needs of the population being served.
AI Innovations Description
Based on the information provided, the recommendation to improve access to maternal health and address the negative impact of placental malaria on infant weight development could be to implement targeted interventions for pregnant women in areas with high malaria transmission. These interventions could include:

1. Increased antenatal care: Pregnant women should have access to regular antenatal care visits, where they can receive appropriate screening and treatment for malaria. This can help detect and manage placental malaria early on, reducing its impact on infant weight development.

2. Malaria prevention measures: Pregnant women should be educated about the importance of using insecticide-treated bed nets and taking preventive antimalarial medication, such as intermittent preventive treatment in pregnancy (IPTp). These measures can help reduce the risk of placental malaria and its negative effects on infant growth.

3. Improved access to diagnostic tools: Health facilities in areas with high malaria transmission should have access to reliable diagnostic tools, such as placental histology, to accurately diagnose placental malaria. This can help identify pregnant women at risk and ensure appropriate interventions are provided.

4. Nutritional support: Pregnant women affected by placental malaria should receive adequate nutritional support to mitigate the negative impact on infant weight development. This can include access to balanced diets, nutritional supplements, and counseling on healthy eating during pregnancy.

5. Long-term monitoring and follow-up: Infants born to mothers with placental malaria should be closely monitored during their first year of life to assess their growth and development. This can help identify any potential long-term effects and provide appropriate interventions if needed.

By implementing these recommendations, it is possible to improve access to maternal health and reduce the negative impact of placental malaria on infant weight development, ultimately improving the overall health and well-being of both mothers and their children.
AI Innovations Methodology
To improve access to maternal health, here are some potential recommendations:

1. Mobile Clinics: Implementing mobile clinics that can travel to remote areas or underserved communities to provide maternal health services. These clinics can offer prenatal care, postnatal care, and education on maternal health.

2. Telemedicine: Utilizing telemedicine technology to provide virtual consultations and remote monitoring for pregnant women. This can help overcome geographical barriers and provide access to specialized care for high-risk pregnancies.

3. Community Health Workers: Training and deploying community health workers who can provide basic maternal health services, education, and support in their own communities. These workers can bridge the gap between healthcare facilities and the community, ensuring that pregnant women receive the care they need.

4. Maternal Health Vouchers: Implementing a voucher system that provides financial assistance to pregnant women, enabling them to access maternal health services at healthcare facilities. This can help reduce financial barriers and increase utilization of healthcare services.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Identify the specific population or region where the recommendations will be implemented.

2. Collect baseline data: Gather data on the current access to maternal health services, including the number of pregnant women receiving care, distance to healthcare facilities, and any existing barriers.

3. Define indicators: Determine the key indicators that will be used to measure the impact of the recommendations, such as the number of pregnant women accessing prenatal care or the reduction in maternal mortality rates.

4. Simulate implementation: Use modeling techniques to simulate the implementation of the recommendations. This could involve creating a virtual representation of the target population and simulating the effects of the recommendations on access to maternal health services.

5. Analyze results: Evaluate the simulated results to determine the impact of the recommendations on improving access to maternal health. This could include comparing the baseline data with the simulated data to measure changes in key indicators.

6. Refine and iterate: Based on the results, refine the recommendations and simulation methodology as needed. Repeat the simulation process to further optimize the impact of the recommendations.

By following this methodology, policymakers and healthcare providers can gain insights into the potential impact of different innovations on improving access to maternal health and make informed decisions on implementation strategies.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email